People News

As a result of Halo Pharmaceutical's partnership with DeMelleBioPharma, George Bobotas has joined Halo as chief scientific officer. Bobotas has been president and managing partner of DeMelleBioPharma since 2008. Prior to that, Bobotas worked for Reliant Pharmaceuticals as VP, scientific affairs.

April 21, 2009

5:48 pm

As a result of Halo Pharmaceutical‘s partnership with DeMelleBioPharma, George Bobotas has joined Halo as chief scientific officer. Bobotas has been president and managing partner of DeMelleBioPharma since 2008. Prior to that, Bobotas worked for Reliant Pharmaceuticals as VP, scientific affairs.

Contract sales firm PDI has announced the appointment of David Kerr to senior vice president of business development. Kerr was most recently SVP of commercial business at Endo Pharmaceuticals.

From Our Partners

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

Partner Content

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

The evolution of patient needs and rising consumer expectations are shaping a new era in healthcare — one that calls for a paradigm shift in the pharmaceutical industry's approach to patient support.

Omnichannel activation without omniburden

Partner Content

Omnichannel activation without omniburden

Explore solutions for practically implementing omnichannel approaches into your go-to-market activation.

Taking a patient-centric approach to privacy

Partner Content

Taking a patient-centric approach to privacy

This podcast will explore ways to deliver tailored content that activates, educates and empowers patients while prioritizing privacy and consent.

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.